{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:59:15Z","timestamp":1783641555051,"version":"3.55.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,4,24]],"date-time":"2007-04-24T00:00:00Z","timestamp":1177372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00104-007-1339-z","type":"journal-article","created":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T14:09:09Z","timestamp":1177337349000},"page":"351-355","source":"Crossref","is-referenced-by-count":15,"title":["Isch\u00e4mische Anastomosenperforation im Bereich einer Ileotransversostomie unter Therapie mit Bevacizumab","Ischemic anastomotic bowel perforation during treatment with bevacizumab 10\u00a0months after surgery"],"prefix":"10.1007","volume":"79","author":[{"given":"K.","family":"Abbrederis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schuhmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,24]]},"reference":[{"key":"1339_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1200\/jco.2005.23.16_suppl.2","volume":"23","author":"Giantonio","year":"2005","unstructured":"Giantonio BJ, Catalano PJ, Meropol NJ et al. (2005) High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer. Results from the Eastern Cooperative Oncology Group (ECOG) study E3200 Abstract. J Clin Oncol 23: 2","journal-title":"J Clin Oncol"},{"key":"1339_CR2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335","journal-title":"N Engl J Med"},{"key":"1339_CR3","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1200\/JCO.2005.00.232","volume":"23","author":"Kabbinavar","year":"2005","unstructured":"Kabbinavar FF, Hambleton J, RD Mass et al. (2005) Combined analysis of efficacy: The addition of bevacizumab to fluorouracil\/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23: 3706","journal-title":"J Clin Oncol"},{"key":"1339_CR4","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.ijrobp.2005.12.004","volume":"54","author":"Lordick","year":"2006","unstructured":"Lordick F, Geinitz H, Theisen J, Sendler A et al. (2006) Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: Report of three cases. Int J Radiat Oncol Biol Phys 54: 1295","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1339_CR5","unstructured":"Lenz HJ (2005) Antiangiogenic agents in cancer therapy. Oncology (Huntingt) 4 [Suppl 3] 19: 17"},{"key":"1339_CR6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jso.20301","volume":"91","author":"Scappaticci","year":"2005","unstructured":"Scappaticci FA, Fehrenbacher L, Cartwright Tet al. (2005) Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol 91: 173","journal-title":"J Surg Oncol"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-007-1339-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-007-1339-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-007-1339-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:23:14Z","timestamp":1558581794000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-007-1339-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,24]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1007\/s00104-007-1339-z","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,24]]}}}